Get startedLog in
    Picture of Beigene logo

    6160 — Beigene Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Beigene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARSARSARS
    Standards:
    CAS
    CAS
    CAS
    CAS
    CAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,9542,1207,5899,56617,423
    Cost of Revenue
    Gross Profit2,4631,6346,5287,66314,713
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses9,70613,36717,16822,99226,234
    Operating Profit-6,752-11,247-9,580-13,425-8,810
    Other Net Non Operating Costs
    Net Income Before Taxes-6,753-11,249-9,579-13,427-6,208
    Provision for Income Taxes
    Net Income After Taxes-6,928-11,407-9,748-13,642-6,716
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-6,915-11,384-9,748-13,642-6,716
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-6,915-11,384-9,748-13,642-6,716
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-5.18-8.53-7.3-10.2-4.95
    Dividends per Share